MARSHALL WACE, LLP - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 63 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$60,681
-28.6%
25,496
+57.6%
0.00%
Q4 2021$85,000
-95.7%
16,178
-94.6%
0.00%
-100.0%
Q2 2021$1,977,000
+248.1%
297,749
+200.7%
0.01%
+200.0%
Q1 2021$568,000
+158.2%
99,013
+624.2%
0.00%
+50.0%
Q2 2020$220,000
-92.4%
13,672
-97.2%
0.00%
-93.1%
Q1 2020$2,907,000
-67.6%
485,229
-28.7%
0.03%
-53.2%
Q4 2019$8,978,000
+42.6%
680,181
+34.2%
0.06%
+24.0%
Q3 2019$6,297,000
-24.1%
507,007
-1.6%
0.05%
-26.5%
Q2 2019$8,298,000
-43.4%
515,405
+10.6%
0.07%
-1.4%
Q1 2019$14,660,000
+270.7%
465,862
+286.8%
0.07%
+72.5%
Q4 2018$3,955,000120,4420.04%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q1 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,300,000$17,160,0002.55%
Alphabet Inc. 699,352$9,231,0000.56%
DAFNA Capital Management LLC 100,000$1,320,0000.45%
JUPITER ASSET MANAGEMENT LTD 705,356$9,311,0000.29%
Artal Group S.A. 500,000$6,600,0000.26%
Cormorant Asset Management, LP 479,988$6,336,0000.25%
MPM BioImpact LLC 39,740$525,0000.19%
Granahan Investment Management 305,158$4,028,0000.18%
Burrage Capital Management LLC 13,113$173,0000.12%
Vident Investment Advisory, LLC 118,866$1,569,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders